SEC Form 4 · accession 0001209191-15-067448
Fluent, Inc. · FLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Aug 21, 2015
Accepted (ET)
Aug 24, 2015 · 7:32 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001460329
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Aug 21, 2015 | P | 10,000 | $6.4449 | A | 4,879,588 | I | By Frost Gamma Investments Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased in multiple transactions at prices ranging from $6.22 to $6.55, with a weighted average price per share of $6.4449.
- F2This Form 4 does not include up to 900,108 shares of common stock of the Issuer that may be issued to Frost Gamma Investments Trust to the extent certain revenue targets are achieved as set forth in that certain Merger Agreement and Plan of Reorganization dated December 14, 2014 to which the Issuer is a party.
- F3These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.